FORMA THERAPEUTICS HLDGS INC's ticker is FMTX and the CUSIP is 34633R104. A total of 87 filers reported holding FORMA THERAPEUTICS HLDGS INC in Q1 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $179,782,000 | +189.6% | 9,011,651 | 0.0% | 3.84% | +131.7% |
| Q2 2022 | $62,090,000 | -25.9% | 9,011,651 | 0.0% | 1.66% | -9.5% |
| Q1 2022 | $83,808,000 | -34.6% | 9,011,651 | 0.0% | 1.83% | -19.0% |
| Q4 2021 | $128,146,000 | -38.7% | 9,011,651 | 0.0% | 2.26% | -22.0% |
| Q3 2021 | $208,980,000 | -6.8% | 9,011,651 | 0.0% | 2.90% | -19.6% |
| Q2 2021 | $224,300,000 | -11.2% | 9,011,651 | 0.0% | 3.60% | -5.4% |
| Q1 2021 | $252,506,000 | -19.7% | 9,011,651 | 0.0% | 3.81% | -13.4% |
| Q4 2020 | $314,507,000 | -30.0% | 9,011,651 | 0.0% | 4.40% | -46.5% |
| Q3 2020 | $449,141,000 | +7.2% | 9,011,651 | 0.0% | 8.22% | +0.6% |
| Q2 2020 | $418,952,000 | – | 9,011,651 | – | 8.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,565,529 | $43,866,000 | 8.09% |
| Logos Global Management LP | 1,410,000 | $39,508,000 | 3.86% |
| RA Capital Management | 9,011,651 | $252,506,000 | 3.81% |
| Cormorant Asset Management, LP | 4,720,000 | $132,254,000 | 2.95% |
| Artal Group S.A. | 1,000,000 | $28,020,000 | 0.50% |
| Perceptive Advisors | 1,250,000 | $35,025,000 | 0.44% |
| HighVista Strategies LLC | 20,630 | $578,000 | 0.43% |
| HHLR ADVISORS, LTD. | 1,100,000 | $30,822,000 | 0.30% |
| Baker Brothers Advisors | 2,024,876 | $56,737,000 | 0.25% |
| Tekla Capital Management LLC | 149,825 | $4,198,000 | 0.14% |